OMER Stock: Price, Earnings History and SEC Filings
Omeros Corporation (OMER) last traded at $18.44, down 2.69% on the latest session and down 3.2% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $0.02 against an analyst estimate of $-0.27, a beat of 107.4%.
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
OMER earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 12, 2026 | $0.02 | $-0.27 | +107.41% |
| Mar 2026 | May 13, 2026 | $-0.24 | $-0.40 | +40.00% |
| Dec 2025 | Mar 31, 2026 | $3.14 | $-0.55 | +670.91% |
| Sep 2025 | Nov 13, 2025 | $-0.19 | $-0.58 | +67.24% |
OMER beat the analyst EPS estimate in 4 of its last 4 reported quarters. Source: Nasdaq.
How OMER reacts to earnings
Across its last 8 earnings releases, OMER moved 13.5% on average the next session, in either direction. It rose after 4 of 8 reports.
| Report date | Released | Next-session move |
|---|---|---|
| 2026-08-12 | After close | +26.55% |
| 2026-05-13 | After close | -7.65% |
| 2026-03-31 | After close | +14.39% |
| 2026-01-07 | After close | -4.54% |
| 2025-11-13 | After close | +25.32% |
| 2025-08-14 | After close | +7.04% |
| 2025-05-15 | After close | -18.48% |
| 2025-03-31 | After close | -3.77% |
Based on the dates of earnings-release 8-K filings (SEC EDGAR) and daily closing prices (Yahoo Finance). Past reactions do not predict future ones.
OMER financial history
| Fiscal year | Revenue | Net income | Free cash flow | Net margin | Diluted EPS |
|---|---|---|---|---|---|
| 2020 | $74M | -$138M | -$100M | -187.0% | $-2.41 |
| 2019 | $112M | -$84M | -$60M | -75.6% | $-1.71 |
| 2018 | $30M | -$127M | -$104M | -424.4% | – |
| 2017 | $65M | -$53M | -$37M | -82.5% | – |
Source: annual figures from 10-K filings on SEC EDGAR. The year shown is the calendar year the fiscal year ended. Free cash flow is operating cash flow minus capital spending.
Latest SEC filings for OMER
- 8-K · Oct 30, 2026Officer or director change, Financial statements and exhibits
- 8-K · Aug 13, 2026Officer or director change
- 10-Q · Aug 12, 2026
- 8-K · Aug 12, 2026Results of operations, Financial statements and exhibits
- 8-K · Jul 20, 2026Other events
- 8-K · Jul 6, 2026Other events
- 8-K · Jun 25, 2026Shareholder vote
- 8-K · Jun 18, 2026Other events
- 10-Q · May 13, 2026
- 8-K · May 13, 2026Results of operations, Financial statements and exhibits
Insider filing activity
OMER insiders filed 8 Form 4 reports in the last 90 days. A Form 4 is how directors and executives disclose purchases, sales and grants of company stock. See the individual filings on SEC EDGAR. Many Form 4 filings are routine, such as scheduled sales or option exercises, so check each filing before drawing a conclusion.
Source: SEC EDGAR.
OMER news
No recent headlines found. The live terminal has the full news feed.
About Omeros Corporation
Omeros Corporation (OMER) is a US-listed public company on Nasdaq. The SEC classifies its business as Pharmaceutical Preparations. It is incorporated in WA. Its fiscal year ends in December.